Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bruce Berkowitz’s New Contrarian Bets

Bruce Berkowitz is pretty impressive for a mutual fund manager. We analyzed Berkowitz’s returns using Carhart’s 4-factor model and determined that Berkowitz had an average annual alpha of 3 percentage points per year. Usually mutual funds try to extract every drop of alpha in their successful strategies by expanding their assets and buying index stocks. They keep making money through management fees but their clients couldn’t enjoy any alpha for long periods of time. Berkowitz is different, that’s why we follow his moves.

FAIRHOLME (FAIRX) Bruce Berkowitz

Berkowitz filed his 13F form with the SEC this week and disclosed three new positions, one of which is truly new. Fairholme initiated a $614 Million position in Cisco during the first quarter. Fairholme also sold its entire $1.75 Billion GGP stake and initiated a $892 Million Brookfield Asset Management (BAM) position. Unfortunately Fairholme lost nearly $1 Billion because of the decline in AIG shares. This decline prompted Berkowitz to spend an additional $264 Million on AIG warrants.

Berkowitz also initiated 5 other new but very small positions in Telefonica (TEF), Eli Lilly (LLY), Bristol Myers (BMY), GlaxoSmithKline (GSK), and AstraZeneca (AZN). Fairholme sold out its stake in Humana (HUM), Wellcare Health Plans (WCG), and General Electric (GE).

Several hedge funds got rid of their CSCO bets during the first quarter as the company kept disappointing. David Tepper’s Appaloosa, Larry Robbins’ Glenview Capital, and Alan Fournier’s Pennant Capital sold their entire CSCO stakes. Phill Gross’ Adage reduce its holdings by nearly 10%. On the opposite side of the trade were Eddie Lampert and Whitney Tilson.

The table below provides a summary of Berkowitz’s portfolio activity during the first quarter:

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!